HIGHLIGHTS
- who: Muhammad Haseeb ul Rasool and collaborators from the Medicine, Tufts Medical Center, Medford, USA have published the research: Review began 09/13/2022 Review ended 09/19/2022 Published 09/24/2022 u00a9 Copyright, in the Journal: (JOURNAL) of September/24,/2022
- what: The aim of this review was to perform a clinical comparison of TAVR vs. SAVR and to analyze the Health Index Factor (HIF) that makes TAVR a treatment of choice in asymptomatic AS patients. The primary outcome of the study is to document all-cause death and two years` risk of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.